AWM Investment Company, Inc. - Apr 8, 2021 Form 4 Insider Report for INVO Bioscience, Inc. (INVO)

Role
10%+ Owner
Signature
Adam Stettner
Stock symbol
INVO
Transactions as of
Apr 8, 2021
Transactions value $
$420,488
Form type
4
Date filed
5/11/2021, 05:04 PM
Previous filing
May 11, 2021
Next filing
May 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INVO Common Stock Purchase $61.3K +15K +1.42% $4.08 1.07M Apr 8, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $113K +27.8K +2.6% $4.08 1.1M Apr 9, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $52.6K +13.1K +1.2% $4.00 1.11M Apr 12, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $23K +5.8K +0.52% $3.97 1.11M Apr 13, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $67.7K +17.2K +1.54% $3.95 1.13M Apr 14, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $1.24K +322 +0.03% $3.85 1.13M Apr 15, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $34.5K +9K +0.8% $3.83 1.14M Apr 16, 2021 By Limited Partnership F1
transaction INVO Common Stock Purchase $21.1K +5.8K +0.51% $3.64 1.15M Apr 19, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $13.6K +3.5K +0.31% $3.90 1.15M Apr 20, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $16.9K +3.8K +0.33% $4.44 1.15M Apr 27, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $1.79K +465 +0.04% $3.85 1.15M May 4, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $9.46K +2.46K +0.21% $3.85 1.16M May 4, 2021 By Limited Partnerships F1
transaction INVO Common Stock Purchase $3.85K +1K +0.09% $3.85 1.16M May 6, 2021 By Limited Partnerships F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a weighted average price.
F2 AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay) and Special Situations Life Sciences Fund, L.P. (LS). (LS and together with QP and Cay, the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 399,809 shares of Common Stock of the Issuer (the Shares) held by QP, 133,266 Shares held by Cay and 625,000 Shares held by LS.
F3 Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.